oxycodegol
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
2
Phase 4
0
Earliest trial started Jun 1, 2012 (NCT01619839)
Timeline
Indications
Mechanism of action
- Mu opioid receptorAGONIST
OPRM agonist
Chemistry & pharmacology
Loading structure…
SMILES
COCCOCCOCCOCCOCCOCCO[C@H]1CCC2(O)[C@H]3Cc4ccc(OC)c5c4[C@@]2(CCN3C)[C@H]1O5- Mol. weight
- 595.73 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4297632 ↗
Also known as
- nktr-181
- nktr-181
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03802227 | Phase 1 | Oct 22, 2018 | Nektar Therapeutics |
| NCT02367820 | Phase 3 | Mar 1, 2015 | Nektar Therapeutics |
| NCT02362672 | Phase 3 | Feb 1, 2015 | Nektar Therapeutics |
| NCT01619839 | Phase 2 | Jun 1, 2012 | Nektar Therapeutics |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Nektar Therapeutics | For profit | 4 | 4 | 3 | 2012 |
1 organizations
Page 1 / 1